CFO leaves biotechnology company
Silence finance chief steps down
The chief financial officer of
Silence
Therapeutics has resigned.
Melvyn Davies, who was also company secretary, had been with Silence for 15
years. He will assist the company for up to three months until they find a
successor.
Silence, which specialises in treating serious diseases with biotechnology,
also announced the resignation of Iain Ross, chairman and a director of the
board. The board has appointed Jerry Randall, senior independent director, to
replace him.
Randall said: “I would like to extend my own and the board’s heartfelt thanks
to both Iain and Melvyn for all they have contributed to Silence.”
Further reading:
Female
accountants paid 60% less than men
Davis
Service Group swoops for board finance experts
Smiths
FD retires after 28 years